You don’t have products yet

View Products

Anti-CD3 Antibody for Lymphoma Tumor Diagnosis

BioGenex presents Anti-CD3 antibody for Lymphoma tumor diagnosis. CD3 (Cluster of Differentiation 3) is a complex of proteins that associates directly with the T cell antigen receptor (TCR). CD3 is composed of five invariant polypeptide chains that associate to form three dimers. The five invariant chains of CD3 are labeled gamma, delta, epsilon, zeta, and eta. 
The CD3 is involved in T cell development and survival. It is expressed on T cells in Thymus, peripheral lymphoid tissue, blood and bone marrow. CD3 is a commonly used marker for identification of T cell and T cell derived malignancies. This CD3 antibody has been validated by the 9th International Conference on Human Leukocyte Differentiation Antigens (HLDA9).
BioGenex offers ready-to-use (RTU) & concentrated forms of antibodies for both manual & automated systems which are best-in-class for clinicopathological diagnosis & drug discovery. It enables pathologists & clinicians to precisely diagnose and improve life expectancy.